Welcome to Episode 23 of Cardiovascular Matters! In this inspiring episode, Terry Roberts shares his incredible journey of losing over 100 pounds in just eight months, thanks to groundbreaking GLP-1 medications and guidance from Dr. Craig Walker, founder of the Cardiovascular Institute of the South.

In this episode, you’ll learn:

• The impact of obesity on cardiovascular health and overall well-being.
• How GLP-1 medications work to suppress appetite and improve metabolic health.
• The benefits of combining medications with lifestyle changes for sustainable weight loss.
• Terry's personal experience with GLP-1 therapy and how it transformed his life.

Dr. Walker also explains the science behind obesity, the challenges of traditional diets, and why GLP-1 medications are a game-changer for those struggling with their weight. Whether you're looking to improve your health or help a loved one, this episode offers valuable insights into achieving lasting results.

--- For more information, visit: ---
Facebook Page: facebook.com/profile.php?id=61558432490919
www.cardio.com

Welcome to Episode 22 of Cardiovascular Matters! In this engaging discussion, Terry Roberts and Dr. Craig Walker, founder of the Cardiovascular Institute of the South, dive deep into one of the most asked questions about cardiovascular health: statins and cholesterol management.

In this episode, Dr. Walker explains:

• Why statins are a cornerstone of cardiovascular treatment.
• The science behind cholesterol and its role in heart disease.
• How statins work to lower LDL cholesterol and improve heart health.
• Common concerns and misconceptions about statins, including side effects.
• Alternative treatments for patients who cannot tolerate statins.

Dr. Walker also shares practical tips for combining lifestyle changes with medical treatments to achieve optimal cholesterol levels. Whether you're a patient or a caregiver, this episode provides clear answers and actionable advice to help you or your loved ones manage cardiovascular health effectively.

If you have high cholesterol or are considering treatment options, don't miss this essential guide from one of the leading voices in cardiology.

📌 Don't forget to like, share, and subscribe!

For more information, visit:
Facebook Page: facebook.com/profile.php?id=61558432490919
www.cardio.com

In this insightful episode of Cardiovascular Matters, host Terry Roberts and renowned cardiologist Dr. Craig Walker delve into the groundbreaking technology of renal denervation and its profound implications for the treatment of hypertension.

High blood pressure, or hypertension, is a major risk factor for a host of cardiovascular complications, including heart attack, stroke, heart failure, and kidney damage. Traditionally, the management of hypertension has relied heavily on a pharmacological approach, with patients often required to take multiple medications to control their blood pressure. However, this approach can come with its own set of challenges, including medication side effects, adherence issues, and the ongoing financial burden of lifelong treatment.

Enter renal denervation - a minimally invasive, catheter-based procedure that targets the sympathetic nerves surrounding the kidney arteries. By disrupting these nerves, renal denervation has been shown to significantly lower blood pressure, often to the point where patients can reduce or even eliminate their reliance on antihypertensive medications.

Dr. Walker explains the underlying mechanisms behind renal denervation and how it can address the root causes of hypertension, rather than simply masking the symptoms. He shares insights from clinical trials, highlighting the impressive and sustained reductions in blood pressure achieved with this innovative approach.
Notably, the recent announcement that Medicare and CMS will provide coverage for renal denervation procedures starting in 2025 is a game-changer, making this transformative technology accessible to a wider patient population. This development holds the potential to revolutionize the way we manage hypertension, offering patients a viable alternative to lifelong medication dependence and the associated side effects and costs.

As Terry and Dr. Walker discuss, the implications of renal denervation extend beyond just blood pressure control. They explore the potential for this procedure to positively impact other cardiovascular conditions, such as heart failure, and how it may be utilized in earlier stages of hypertension to prevent the progression of cardiovascular disease.

Listeners will come away from this episode with a deeper understanding of the science behind renal denervation, the clinical evidence supporting its efficacy, and the exciting prospects for its future integration into the standard of care for hypertension management. Join us as we delve into this revolutionary advancement in cardiovascular care.

For more information, visit:
Facebook Page: facebook.com/profile.php?id=61558432490919
www.cardio.com